Quality assessment of delineation and dose planning of early breast cancer patients included in the randomized Skagen Trial 1

Giulio Francolini, Mette S Thomsen, Esben S Yates, Carine Kirkove, Ingelise Jensen, Egil S Blix, Claus Kamby, Mette H Nielsen, Mechthild Krause, Martin Berg, Ingvil Mjaaland, Andreas Schreiber, Unn-Miriam Kasti, Kristian Boye, Birgitte V Offersen

Research output: Contribution to journalJournal articleResearchpeer-review

2 Citations (Scopus)
Original languageEnglish
JournalRadiotherapy & Oncology
Volume123
Issue number2
Pages (from-to)282-287
Number of pages6
ISSN0167-8140
DOIs
Publication statusPublished - 2017

Keywords

  • Journal Article

Fingerprint Dive into the research topics of 'Quality assessment of delineation and dose planning of early breast cancer patients included in the randomized Skagen Trial 1'. Together they form a unique fingerprint.

  • Cite this

    Francolini, G., Thomsen, M. S., Yates, E. S., Kirkove, C., Jensen, I., Blix, E. S., Kamby, C., Nielsen, M. H., Krause, M., Berg, M., Mjaaland, I., Schreiber, A., Kasti, U-M., Boye, K., & Offersen, B. V. (2017). Quality assessment of delineation and dose planning of early breast cancer patients included in the randomized Skagen Trial 1. Radiotherapy & Oncology, 123(2), 282-287. https://doi.org/10.1016/j.radonc.2017.03.011